Drug Profile
AR 1012
Alternative Names: AR1012Latest Information Update: 28 Jul 2020
Price :
$50
*
At a glance
- Originator AriBio
- Class Small molecules
- Mechanism of Action Histone deacetylase modulators; Wnt signalling pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Eye disorders; Glaucoma
Most Recent Events
- 28 Jul 2020 No recent reports of development identified for research development in Eye-disorders in South Korea
- 28 Jul 2020 No recent reports of development identified for research development in Glaucoma in South Korea
- 01 Jun 2016 Early research in Eye disorders in South Korea (unspecified route)